These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18497878)

  • 1. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.
    García C; Aranda J; Arnold E; Thébault S; Macotela Y; López-Casillas F; Mendoza V; Quiroz-Mercado H; Hernández-Montiel HL; Lin SH; de la Escalera GM; Clapp C
    J Clin Invest; 2008 Jun; 118(6):2291-300. PubMed ID: 18497878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoinhibins: novel inhibitors of ocular angiogenesis.
    Clapp C; Thebault S; Arnold E; García C; Rivera JC; de la Escalera GM
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E772-8. PubMed ID: 18544641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins.
    Arnold E; Rivera JC; Thebault S; Moreno-Páramo D; Quiroz-Mercado H; Quintanar-Stéphano A; Binart N; Martínez de la Escalera G; Clapp C
    Diabetes; 2010 Dec; 59(12):3192-7. PubMed ID: 20823101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of phosphorylatable endothelial nitric oxide synthase at Ser-1177 for vasoinhibin-mediated inhibition of endothelial cell migration and proliferation in vitro.
    García C; Nuñez-Anita RE; Thebault S; Arredondo Zamarripa D; Jeziorsky MC; Martínez de la Escalera G; Clapp C
    Endocrine; 2014 Mar; 45(2):263-70. PubMed ID: 23640371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability.
    Ramírez M; Wu Z; Moreno-Carranza B; Jeziorski MC; Arnold E; Díaz-Lezama N; Martínez de la Escalera G; Colosi P; Clapp C
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8944-50. PubMed ID: 22003113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy.
    Triebel J; Macotela Y; de la Escalera GM; Clapp C
    IUBMB Life; 2011 Oct; 63(10):806-10. PubMed ID: 21913303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
    Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoinhibin reduces joint inflammation, bone loss, and the angiogenesis and vasopermeability of the pannus in murine antigen-induced arthritis.
    Ortiz G; Ledesma-Colunga MG; Wu Z; García-Rodrigo JF; Adan N; Martínez de la Escalera G; Clapp C
    Lab Invest; 2020 Aug; 100(8):1068-1079. PubMed ID: 32341517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats.
    Adán-Castro E; Siqueiros-Márquez L; Ramírez-Hernández G; Díaz-Lezama N; Ruíz-Herrera X; Núñez FF; Núñez-Amaro CD; Robles-Osorio ML; Bertsch T; Triebel J; Martínez de la Escalera G; Clapp C
    J Neuroendocrinol; 2022 Apr; 34(4):e13091. PubMed ID: 35078262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress.
    Arredondo Zamarripa D; Díaz-Lezama N; Meléndez García R; Chávez Balderas J; Adán N; Ledesma-Colunga MG; Arnold E; Clapp C; Thebault S
    Front Cell Neurosci; 2014; 8():333. PubMed ID: 25368550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of diabetic retinopathy with angiopoietin-1.
    Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
    Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
    Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases.
    Maines LW; French KJ; Wolpert EB; Antonetti DA; Smith CD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5022-31. PubMed ID: 17065523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
    Duan J; Du C; Shi Y; Liu D; Ma J
    Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan Inhibits Nitric Oxide Production and Vessel Relaxation via Protein Phosphatase 2A-mediated Endothelial NO Synthase-Ser
    Cho DH
    J Korean Med Sci; 2019 Nov; 34(42):e266. PubMed ID: 31674157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of the prolactin/vasoinhibin axis.
    Triebel J; Bertsch T; Bollheimer C; Rios-Barrera D; Pearce CF; Hüfner M; Martínez de la Escalera G; Clapp C
    Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(10):R1193-203. PubMed ID: 26310939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
    You JJ; Yang CH; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.
    Du Y; Sarthy VP; Kern TS
    Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R735-41. PubMed ID: 15371279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.